Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹307.00
Market cap: ₹8,675 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.6×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Jul 2026 15:00 IST NSE

Suven Life Sciences Management Change

SUVEN Life Sciences Ltd re‑appointed Vajja Sambasiva Rao as a non‑executive independent director. The appointment is effective from 21 Jan 2027 for a 60‑month term.

Read the filing ↗